Search Within

Joachim Yahalom

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (47)
  2. Journal Article (22)
  3. Research Letter (2)
  4. Conference Paper (1)
Groups
  1. Bone Marrow Transplant (72)
  2. Center for Hematologic Malignancies (72)
  3. Department of Medicine (72)
  4. Hematologic Malignancies, Division of (72)
  5. Radiation Oncology, Department of (72)
  6. Survivorship Research (72)

More Groups

People
  1. Michael Scordo (45)
  2. Brandon Imber (41)
  3. Gunjan Shah (35)
  4. Maria Palomba (35)
  5. Miguel-Angel Perales (34)
  6. Craig Sauter (29)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (15)
  4. 2022 (9)
  5. 2021 (4)
  6. 2020 (6)

More Years

Publications
  1. Blood (23)
  2. International Journal of Radiation Oncology, Biology, Physics (10)
  3. Hematological Oncology (9)
  4. Neuro-Oncology (4)
  5. Biology of Blood and Marrow Transplantation (3)
  6. British Journal of Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. Elsevier Inc. (19)
  3. Wiley Blackwell (9)
  4. Oxford University Press (4)
  5. John Wiley & Sons (3)
  6. Nature Publishing Group (3)

More Publishers

Results (72)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation
    Journal Article

    Correa, D. D.; Braun, E.; Kryza-Lacombe, M.; Ho, K. W.; Reiner, A. S.; Panageas, K. S.; Yahalom, J.; Sauter, C. S.; Abrey, L. E.; DeAngelis, L. M.; more...
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Highly favorable outcomes with RT followed by ASCT in low/low‐intermediate secondary age adjusted IPI rel/ref DLBCL patients refractory to salvage chemotherapy
    Meeting Abstract

    Yang, J. C.; Chau, K. W.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; DeSelm, C.; Batlevi, C.; Dahi, P. B.; Giralt, S.; Noy, A. M.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • The outcome of patients with non-chemosensitive relapsed and refractory DLBCL salvaged with radiation therapy followed by autologous stem cell transplant
    Meeting Abstract

    Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Patients with relapsed/refractory large cell lymphoma who were also refractory to salvage chemotherapy: Outcome with salvage radiation therapy followed by autologous stem cell transplant
    Meeting Abstract

    Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant
    Journal Article

    Vardhana, S.; Hamlin, P. A.; Yang, J.; Zelenetz, A.; Sauter, C. S.; Matasar, M. J.; Ni, A.; Yahalom, J.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save